Download video

TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors

116 views

VJOncology

1 year ago

TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors

TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors

TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
4:27
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
by You and Lung Cancer
HARMONi-2 Trial: Ivonescimab vs Pembrolizumab in PD-L1+ NSCLC | Phase 3 Results (PL02.04)
12:07
HARMONi-2 Trial: Ivonescimab vs Pembrolizumab in PD-L1+ NSCLC | Phase 3 Results (PL02.04)
by Cancer Research and Statistic Foundation
#Pembrolizumab | Uses, Dosage, Side Effects and Mechanism | Keytruda
8:38
#Pembrolizumab | Uses, Dosage, Side Effects and Mechanism | Keytruda
by He-InFo
PFAS Exposure and Epigenetics in the Firefighter Cancer Cohort Study
58:20
PFAS Exposure and Epigenetics in the Firefighter Cancer Cohort Study
by Collaborative for Health \& Environment
S1 Episode 4: Managing Lung Cancer With Neoadjuvant and Adjuvant Therapy
24:30
S1 Episode 4: Managing Lung Cancer With Neoadjuvant and Adjuvant Therapy
by Medscape
Pembrolizumab and the significance of PD-L1 for lung cancer
0:56
Pembrolizumab and the significance of PD-L1 for lung cancer
by VJOncology
Cancer Immune Checkpoint Inhibitors
5:33
Cancer Immune Checkpoint Inhibitors
by Harvard Medical School Continuing Education
How Does Anti-PD-1 Therapy Help Fight Cancer?
1:07
How Does Anti-PD-1 Therapy Help Fight Cancer?
by Johns Hopkins Medicine
Dr. Diaz on Pembrolizumab for CRC
1:15
Dr. Diaz on Pembrolizumab for CRC
by OncLive
Introduction to Immune Checkpoint Inhibitor (ICI) Immunotherapy
5:10
Introduction to Immune Checkpoint Inhibitor (ICI) Immunotherapy
by Princess Margaret Cancer Centre
Managing acute and long-term side effects in checkpoint inhibitors for melanoma
0:34
Managing acute and long-term side effects in checkpoint inhibitors for melanoma
by VJOncology
Merck's Keytruda (pembrolizumab) mechanism of action explained
4:00
Merck's Keytruda (pembrolizumab) mechanism of action explained
by Hypertunity
Checkpoint Inhibitors in Second and Third-line
4:19
Checkpoint Inhibitors in Second and Third-line
by OncLive
Advanced Colorectal Cancer Clinical Trial
3:08
Advanced Colorectal Cancer Clinical Trial
by Hoosier Cancer Research Network